CV Shariat_AKH - Vienna OMI

More documents

Recommendations

Info

for urothelial carcinoma of the bladder. Urology. 2011 Jan 20. [Epub ahead of print] PMID:21256568.231. Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, WaltonTJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M,Karakiewicz PI, Ficarra V, Novara G: Concomitant carcinoma in situ as an independentprognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenteranalysis of 772 patients. World J Urol. 2011 Jan 20. [Epub ahead of print] PMID: 21249372.232. Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W,Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP:Discrepancy between clinical and pathological stage: external validation of the impact onprognosis in an international radical cystectomy cohort. BJU Int. 2011 Jan 18. [Epub ahead ofprint] PMID: 21244604.233. Mazzola CR, Ghoneim T, Shariat SF: [Emerging biomarkers for the diagnosis, staging andprognosis of prostate cancer].Prog Urol. 2011 Jan;21(1):1-10. Epub 2010 Aug 14. French. PMID:21193139234. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Langner C,Montorsi F, Bolenz C, Margulis V.: Prognostic Effect of Urinary Bladder Carcinoma In Situ onClinical Outcome of Subsequent Upper Tract Urothelial Carcinoma. Urology. 2010 Dec 15.PMID: 21167566235. Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D,Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M,Sagalowsky AI, Lotan Y, Shariat SF.: Disease-free survival at 2 or 3 years correlates with 5-yearoverall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. JUrol. 2010 Dec 16. PMID: 21167527236. Thuret R, Sun M, Abdollah F, Budaus L, Lughezzani G, Liberman D, Morgan M, Johal R,Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.: Tumorgrade improves the prognostic ability of American Joint Committee on cancer stage in patientswith penile carcinoma. J Urol. 2010 Dec 16. PMID: 21167526237. Ahallal Y, Shariat SF, Chade DC, Mazzola C, Reuter VE, Sandhu JS, Laudone VP, TouijerKA, Guillonneau BD.: Pilot study of salvage laparoscopic prostatectomy for the treatment ofrecurrent prostate cancer. BJU Int. 2010 Dec 16. PMID: 21166755238. Budäus L, Abdollah F, Sun M, Johal R, Morgan M, Thuret R, Zorn KC, Lughezzani G, IsbarnH, Haese A, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI.: The impact ofsurgical experience on total hospital charges for minimally invasive prostatectomy: a populationbasedstudy. BJU Int. 2010 Dec 13. PMID: 21156018239. Sfakianos J, Shariat SF, Favaretto RL, Rioja J, Herr HW: Impact of smoking on outcomes afterintravesical Bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of thebladder. BJU Int. 2010 Nov 29. [Epub ahead of print] PMID: 2111461240. Youssef RF, Shariat SF, Kapur P, Kabbani W, Ghoneim T, King E, Cockburn A, Mosbah A,Abol-Enein H, Ghoneim M, Lotan Y. Expression of cell cycle-related molecular markers inpatients treated with radical cystectomy for squamous cell carcinoma of the bladder. Hum Pathol.2010 Nov 25. [Epub ahead of print] PMID: 21111452.241. Sun M, Abdo A, Abdollah F, Schmitges J, Thuret R, Jeldres C, Shariat SF, Perrotte P,Karakiewicz PI. Management of upper urinary tract urothelial carcinoma. Expert Rev AnticancerTher. 2010 Dec; PMID: 21110761.242. Youssef R, Kapur P, Kabbani W, Shariat SF, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y.Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value ofcyclooxygenase-2 expression. BJU Int. 2010 Nov 24.[Epub ahead of print] PMID: 21105986.243. Lowrance WT, Tarin TV, Shariat SF. Evidence-based comparison of robotic and open radicalprostatectomy. Scientific World Journal. 2010 Nov 16; PMID: 21103791.244. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE,Skinner E,Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y,www.vienna-omi.at 28.08.2013
Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T2N0 bladder cancerafter radical cystectomy. BJU Int. 2010 Nov 19.[Epub ahead of print] PMID: 21087453.245. Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ,Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI,Shariat SF. Oncological outcomes after laparoscopic and open radical nephroureterectomy:results from an international cohort. BJU Int. 2010 Nov 15.[Epub ahead of print] PMID:21078048.246. Mir C, Shariat SF, Van Der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S,Vajpeyi R, Kuk C, Alkhateeb S, Morote J, Van Rhijn BW, Bostrom P, Yao J, Miyamoto H, JewettM, Fleshner N, Messing E, Zlotta AR. Loss of androgen receptor expression is not associated withpathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.BJU Int. 2010 Nov 10.[Epub ahead of print] PMID: 21070579.247. Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT,Eastham JA. Prognostic significance of lymphovascular invasion in radical prostatectomyspecimens. BJU Int. 2010 Nov 2.[Epub ahead of print] PMID: 21050364.248. Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F,Patard JJ, Perrotte P, Karakiewicz PI. Age-Adjusted Incidence, Mortality, and Survival Rates ofStage-Specific Renal Cell Carcinoma in North America: A Trend Analysis. Eur Urol. 2010 Oct27. [Epub ahead of print] PMID: 21035250.249. Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Rigatti P,Montorsi F, Karakiewicz PI. A Competing-Risks Analysis of Survival After Alternative TreatmentModalities for Prostate Cancer Patients: 1988-2006. Eur Urol. 2010 Oct 14. [Epub ahead of print]PMID: 20965646.250. Budäus L, Sun M, Abdollah F, Zorn KC, Morgan M, Johal R, Liberman D, Thuret R, Isbarn H,Salomon G, Haese A, Montorsi F, Shariat SF, Perrotte P, Graefen M, Karakiewicz PI. Impact ofSurgical Experience on In-Hospital Complication Rates in Patients Undergoing MinimallyInvasive Prostatectomy: A Population-Based Study. Ann Surg Oncol. 2010 Oct 16. [Epub aheadof print] PMID: 20953720.251. Budäus L, Abdollah F, Sun M, Morgan M, Johal R, Thuret R, Zorn KC, Isbarn H, Shariat SF,Montorsi F, Perrotte P, Graefen M, Karakiewicz PI. Annual surgical caseload and open radicalprostatectomy outcomes: improving temporal trends. J Urol. 2010 Dec; Epub 2010 Oct 16. PMID:20952010.252. Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, ShariatSF. Tissue-based molecular markers for bladder cancer. Minerva Urol Nefrol. 2010 Sep; PMID:20940694.253. Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F,Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF,Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF. Macroscopic sessile tumor architecture is apathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. 2010Oct 6. [Epub ahead of print] PMID: 20933445.254. Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF,Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. A population-basedcomparison of cancer-control rates between radical and partial nephrectomy for T1A renal cellcarcinoma. Urology. 2010 Oct; PMID: 20932408.255. Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ,Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W,Karakiewicz PI, Ficarra V, Novara G. Gender differences in radical nephroureterectomy for uppertract urothelial carcinoma. World J Urol. 2010 Oct 1. [Epub ahead of print] PMID: 20886219.256. Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, SchröderFH, Scattoni V. Optimizing Performance and Interpretation of Prostate Biopsy: A CriticalAnalysis of the Literature. Eur Urol. 2010 Sep 4.[Epub ahead of print] PMID: 20884114.257. Liberman D, Alasker A, Sun M, Ismail S, Lughezzani G, Jeldres C, Budaus L, Thuret R,Shariat SF, Widmer H, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI. Radical cystectomywww.vienna-omi.at 28.08.2013
Page 1 and 2: SHAHROKH F. SHARIAT, MDProfessor an
Page 3 and 4: E D U C A T I O N & M E D I C A L T
Page 5 and 6: • Glaxo SmithKline Scholar Award,
Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
Page 9 and 10: • Leading Physician of the World
Page 11 and 12: Weill Cornell Medical Center, Princ
Page 13 and 14: Inventor: Shahrokh ShariatThe prese
Page 15 and 16: • Chair of Sessions - The Inaugur
Page 17 and 18: • Guest Editor of special issue o
Page 19 and 20: • Visiting Professor, Division of
Page 21 and 22: Ablative therapy for small renal co
Page 23 and 24: Bladder cancer: opportunities for i
Page 25 and 26: 7. Merseburger AS, Herrmann TR, Sha
Page 27 and 28: 36. May M, Ficarra V, Shariat SF, Z
Page 29 and 30: Results from of a Large Multicenter
Page 31 and 32: trends and disparities in the use o
Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
Page 41: Montorsi F, Karakiewicz PI: The imp
Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
Page 51 and 52: 349. Margulis V, Shariat SF, Matin
Page 53 and 54: 378. Karakiewicz PI, Bhojani N, Cap
Page 55 and 56: 410. Shariat SF, Lamb DJ, Iyengar R
Page 57 and 58: 442. Chun FK, Briganti A, Gallina A
Page 59 and 60: cystectomy for primary nontransitio
Page 61 and 62: Slawin KM. Salvage radiotherapy for
Page 63 and 64: 535. Shariat SF, Desai S, Song W, K
Page 65 and 66: 21. SunM., Abdollah F., Schmitges J
Page 67 and 68: progression after radical prostatec
Page 69 and 70: Y., Karakiewicz P.: Assessement of
Page 71 and 72: 50. Shariat S., Karakiewicz P., Fra
Page 73 and 74: predictions in patients with adreno
Page 75 and 76: Schoenberg, G. E. Amiel, S. P. Lern
Page 77 and 78: 113. Claudio Jeldres, Maxime Crepel
Page 79 and 80: (volume 183 issue 4 Page e227)134.
Page 81 and 82: 156. Ramy Youssef, Shahrokh Shariat
Page 83 and 84: Localized .Sunday, May 15, 2011 Ame
Page 85 and 86: Health Conference. 2-5 October 2011
Page 87 and 88: urothelial carcinoma. Poster #155.
Page 89 and 90: supplementation on the prevention o
Page 91 and 92: for metastatic renal cell carcinoma
Page 93 and 94:
muscle-invasive urothelial carcinom
Page 95 and 96:
Shahrokh Shariat Prediction of intr
Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou
show all

CV Shariat_AKH - Vienna OMI

Create successful ePaper yourself

Delete template?

Save as template?